This document is an agent authorization letter from Interfocus.Inc, dated May 23, 2025. It formally authorizes Shenzhen BCTC Testing Co., Ltd to represent Interfocus.Inc in all matters related to equipment authorization. This includes the signing of all necessary documents.
The letter also certifies that Interfocus.Inc is not subject to denial of benefits, including FCC benefits, under Section 5301 of the Anti-Drug Abuse Act of 1988. The authorization is valid for one year from the current date.
The document is signed by Miki Zeng, Manager, with contact information provided as 108 West 13th Street 19801 Wilmington Delaware United States.